Growth post renal-transplantation in children: lessons from the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS)
- PMID: 10084792
Growth post renal-transplantation in children: lessons from the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS)
Abstract
Growth retardation following successful transplantation has been noted since the availability of ESRD care for children more than a quarter of a century ago. During the past decade, data collection and analysis of the NAPRTCS data base have detailed the factors which have an impact on growth in renal allograft recipients transplanted in the cyclosporine era. These analyses have led to the following conclusions. 1. Standardized height (z score) worsens in the majority of pediatric recipients following renal transplantation. 2. Catch-up growth (improvement in standardized height) occurs primarily in recipients <6 years of age at transplantation. Therefore, age at transplantation is a significant factor determining the magnitude of post-transplant growth. 3. Reduced allograft function has a profound negative impact on growth following transplantation. 4. Height deficit at the time of transplantation correlates with increment in height following transplantation. The most profoundly growth-retarded recipients exhibit the greatest increase in standardized height. 5. Race has been identified by NAPRTCS as a factor affecting post-transplant growth. Caucasian recipients exhibit a greater improvement in standardized height compared to African-American and Hispanic recipients. 6. Since serial evaluation of NAPRTCS data indicates that catch-up growth is unlikely to occur in 75% of renal allograft recipients, strategies such as the use of growth hormone would be advantageous in the future.
Similar articles
-
Renal transplantation in children from 1987-1996: the 1996 Annual Report of the North American Pediatric Renal Transplant Cooperative Study.Pediatr Transplant. 1997 Nov;1(2):146-62. Pediatr Transplant. 1997. PMID: 10084775
-
The impact of recombinant human growth hormone treatment during chronic renal insufficiency on renal transplant recipients.J Pediatr. 2000 Mar;136(3):376-82. doi: 10.1067/mpd.2000.103850. J Pediatr. 2000. PMID: 10700696 Clinical Trial.
-
The 12th Annual Report of the North American Pediatric Renal Transplant Cooperative Study: renal transplantation from 1987 through 1998.Pediatr Transplant. 2001 Jun;5(3):215-31. Pediatr Transplant. 2001. PMID: 11422826
-
What have 20 years of data from the North American Pediatric Renal Transplant Cooperative Study taught us about growth following renal transplantation in infants, children, and adolescents with end-stage renal disease?Pediatr Nephrol. 2010 Apr;25(4):739-46. doi: 10.1007/s00467-009-1387-3. Epub 2009 Dec 16. Pediatr Nephrol. 2010. PMID: 20013293 Review.
-
Management of growth retardation in pediatric recipients of renal allografts.Nat Clin Pract Nephrol. 2007 Jun;3(6):318-24. doi: 10.1038/ncpneph0502. Nat Clin Pract Nephrol. 2007. PMID: 17525714 Review.
Cited by
-
Growth impairment shows an age-dependent pattern in boys with chronic kidney disease.Pediatr Nephrol. 2007 Mar;22(3):420-9. doi: 10.1007/s00467-006-0345-6. Epub 2006 Nov 28. Pediatr Nephrol. 2007. PMID: 17131161
-
Inferior allograft outcomes in adolescent recipients of renal transplants from ideal deceased donors.Ann Surg. 2012 Mar;255(3):556-64. doi: 10.1097/SLA.0b013e3182471665. Ann Surg. 2012. PMID: 22330037 Free PMC article.
-
Growth hormone for children with chronic renal failure and on dialysis.Pediatr Nephrol. 2005 May;20(5):618-21. doi: 10.1007/s00467-004-1801-9. Epub 2005 Mar 22. Pediatr Nephrol. 2005. PMID: 15782308
-
Longitudinal growth in children following kidney transplantation: from conservative to pharmacological strategies.Pediatr Nephrol. 2006 Jul;21(7):903-9. doi: 10.1007/s00467-006-0117-3. Epub 2006 May 10. Pediatr Nephrol. 2006. PMID: 16773400 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous